Skip to main content

Table 1 Clinicopathological characteristics according to preoperative NLRs

From: Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer

Group

 

Patients

low NLRs

intermediate NLRs

High NLRs

P-value

   

(< 1.5: n = 99)

(1.5–3.5: n = 245)

(≥3.5: n = 38)

 

Age (years)

< 75

289

78

182

29

0.675

≥75

93

21

63

9

 

Sex

Male

232

57

154

21

0.509

Female

150

42

91

17

 

BMI (Kg/m2)

  

22.3 ± 3.0

22.3 ± 3.2

21.0 ± 3.0

0.049

Smoking History

Yes

240

61

156

23

0.895

No

142

38

89

15

 

PS

0–1

355

94

224

37

0.273

2

27

5

21

1

 

Predicted post PFTsa

≥40

355

95

227

33

0.184

< 40

27

4

18

5

 

Histology

Ad

264

79

166

19

0.003

Others

118

20

79

19

 

Differentiation

Well

125

37

78

10

0.412

Mod/poor

257

62

167

28

 

p-stage

IA

212

62

131

19

0.233

IB

170

37

114

19

 

Child-Pugh Score

5

342

90

220

32

0.539

≥6

40

9

25

6

 

eGFR (ml/min/1.73m2)

≥60

301

85

189

27

0.094

 

< 60

81

14

56

11

 

Albumin (g/dl)

  

4.1 ± 0.29

4.1 ± 0.35

4.1 ± 0.38

0.798

CRP (mg/dl)

  

0.14 ± 0.39

0.22 ± 0.43

0.87 ± 2.18

<0.001

  1. aPredicted postoperative values of FEV1.0 or DLCO less than 40% are defined as high-risk results of pulmonary function tests
  2. Ad adenocarcinoma, BMI body mass index, PFT pulmonary function test, PS performance status, p-stage pathological stage